Vital Therapies (NASDAQ:VTL)

Cell-based therapy targeting the treatment of acute liver failure.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Vital Therapies (NASDAQ:VTL) plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About Vital Therapies (NASDAQ:VTL)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With